Erasin is a potent Erlotinib (HY-50896)-resistance antagonizing STAT3 inhibitor with IC50s of 9.7 and 24 µM against STAT3 and STAT1, respectively. Erasin induces cancer cells apoptosis[1].
Molecular Weight:
349.38
Purity:
96.02
Formula:
C20H19N3O3
Target:
Apoptosis,STAT
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted
